The infectious microscopic viruses invade living cells to reproduce themselves, and causes
chronic infections such as HIV/AIDS, hepatitis B and C, flu, etc. in humans which may lead to …

Viral infection is a major contributor to the global cancer burden. Recent advances have
revealed that seven known oncogenic viruses promote tumorigenesis through shared host …

Aims A newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan,
China (COVID-19). Until today> 2700 deaths from the 80,000 confirmed cases reported …

Abstract Background The Severe acute respiratory syndrome-related coronavirus 2 (SARS-
CoV-2) outbreak originating in Wuhan, China, has raised global health concerns and the …

As of today, there is no antiviral for the treatment of the SARS-CoV-2 infection, and the
development of a vaccine might take several months or even years. The structural …

Infectious diseases like malaria, tuberculosis or HIV are among the leading causes of death
worldwide according to WHO estimations. Nevertheless, the fight against infectious diseases …

Highlights•A LNA–DNA hybrid oligomer (miravirsen) is targeted to a host micro RNA instead
of the pathogen (hepatitis C virus)•Miravirsen demonstrates broad antiviral activity against …

Hepatitis C virus (HCV) affects approx. 3% of the world's population and accounts for ca 300
000 deaths per year. 80% of individuals with HCV develop chronic symptoms which, when …

Nucleotide and nucleoside-based analogue drugs are widely used for the treatment of both
acute and chronic viral infections. These drugs inhibit viral replication due to one or more …

Few studies on royal jelly's (RJ) antiviral activities and toxicity have been conducted. Here,
we investigated the antioxidant properties of RJ that was fractionated into soluble fraction …